The Latest Cardiac and Vascular News
Results previously presented in a Late-Breaking Science Session at the American Heart Association’s 2021 Scientific Sessions Global Phase 3 trial of bentracimab achieved both primary reversal endpoint and co-primary endpoint of clinical hemostasis Bentracimab had no drug-related serious adverse events MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a […]
Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. The procedure took place at the 301 Hospital in Beijing on […]
First therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the Neovasc Reducer™ (“Reducer”) system has been granted Prise en Charge Transitoire (“PECT”) reimbursement in France by the national health authority, Haute Autorité de Santé (“HAS”). The decision […]
Aquilion ONE / PRISM Edition Now Offers Precise IQ Engine (PIQE) DLR* and SilverBeam Filter* OTAWARA, Japan–(BUSINESS WIRE)–Canon Medical is breaking ground once again with the introduction of Precise IQ Engine (PIQE) DLR and SilverBeam filter in the latest version of the Aquilion ONE / PRISM edition. PIQE, super-resolution deep-learning […]
FOUNTAIN VALLEY, CA – MemorialCare Orange Coast Medical Center (OCMC) has announced that its Transcatheter Aortic Valve Replacement (TAVR) Program’s cardiac team recently performed their 100th TAVR procedure. Transcatheter aortic valve replacement (TAVR) is a minimally-invasive procedure that allows the aortic valve in your heart to be replaced with a […]
VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the United Kingdom’s Interventional Procedures Programme at the National Institute for Health and Care Excellence (“NICE”) has issued guidance supporting the implantation of the Neovasc Reducer™ (“Reducer”) in appropriate patients suffering from refractory […]
– Study met its primary endpoint, achieving statistically significant reduction in non-high density lipoprotein cholesterol (non-HDL-C) compared to placebo at all doses tested – Key secondary endpoints were met including statistically significant reductions in triglycerides and angiopoietin-like-3 (ANGPTL3) at all doses tested – Pfizer is continuing to review the findings […]
New study shows hypertensive adults can face six times higher heart attack risk after a bout with the seasonal flu LAKE FOREST, Ill., Nov. 23, 2021 /PRNewswire/ — As cold and flu season intensifies across the U.S., global heart health leader OMRON Healthcare, Inc., is issuing a national health alert to the increased […]
MEMPHIS, Tenn., Nov. 22, 2021 /PRNewswire/ — Tony and Karyn Tanner of Bossier City, La., knew that this day was coming sooner rather than later for their 17-year-old daughter Madi. Born with tetralogy of Fallot (TOF), a congenital heart defect that changes the flow of blood through the heart, she needed a pulmonary valve replacement, […]
ST. LOUIS PARK, Minn., Nov. 22, 2021 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, announced positive 30-day results following the first successful worldwide procedure using multiple chords to a single anchor. The […]
